Preparation and characterization of L-[5- 11C]-glutamine for metabolic imaging of tumors

Journal of Nuclear Medicine

Volumn 53, Issue 1, 2012, Pages 98-105

  Qu, Wenchao ^a   Oya, Shunichi ^a   Lieberman, Brian P ^a   Ploessl, Karl ^a   Wang, Limin ^a   Wise, David R ^b   Divgi, Chaitanya R ^a   Chodosh, Lewis P ^b   Thompson, Craig B ^b   Kung, Hank F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

18F FDG; Gene expression; Myc; PET imaging; Tumor metabolism

Indexed keywords

CARBON 11; GLUTAMINE; RADIOPHARMACEUTICAL AGENT;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DRUG DISTRIBUTION; DRUG UPTAKE; GLIOMA; HYDROLYSIS; IMAGE ANALYSIS; IMAGE QUALITY; ISOTOPE LABELING; MOUSE; NONHUMAN; ONCOLOGICAL PARAMETERS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN METABOLISM; RADIATION DOSE; RADIOACTIVITY; TUMOR METABOLISM;

ANIMALS; ASTROCYTOMA; BIOLOGICAL TRANSPORT; CARBON RADIOISOTOPES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYANIDES; GLIOMA; GLUTAMINE; HUMANS; HYDROLYSIS; MALE; MICE; MICE, TRANSGENIC; POSITRON-EMISSION TOMOGRAPHY; RADIOCHEMISTRY; RATS;

EID: 84855372881     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.093831     Document Type: Article

References (37)

1. Dang C. Rethinking the Warburg effect with myc micromanaging glutamine metabolism. Cancer Res. 2010;70:859-862.
2. Vander Heiden M, Locasale J, Swanson K, et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science. 2010;329:1492-1499.
3. Warburg O. On the origin of cancer cells. Science. 1956;123:309-314.
4. DeBerardinis R, Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2010;29:313-324.
5. Weinberg F, Chandel N. Mitochondrial metabolism and cancer. Ann N Y Acad Sci. 2009;1177:66-73.
6. Rajagopalan KN, Deberardinis RJ. Role of glutamine in cancer: therapeutic and imaging implications. J Nucl Med. 2011;52:1005-1008.
7. Thompson C. Metabolic enzymes as oncogenes or tumor suppressors. N Engl J Med. 2009;360:813-815.
8. Vander Heiden M, Cantley L, Thompson C. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324: 1029-1033.
9. Gillies RJ, Robey I, Gatenby RA. Causes and consequences of increased glucose metabolism of cancers. J Nucl Med. 2008;49(suppl 2):24S-42S. (Pubitemid 351948035)
10. Gambhir SS. Molecular imaging of cancer: from molecules to humans-Introduction. J Nucl Med. 2008;49(suppl 2):1S-4S.
11. Robey IF, Stephen RM, Brown KS, Baggett BK, Gatenby RA, Gillies RJ. Regulation of the Warburg effect in early-passage breast cancer cells. Neoplasia. 2008;10:745-756.
12. Kvamme E, Svenneby G. Effect of anaerobiosis and addition of keto acids on glutamine utilization by Ehrlich ascites-tumor cells. Biochim Biophys Acta. 1960;42:187-188.
13. Wise D, DeBerardinis R, Mancuso A, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA. 2008;105:18782-18787.
14. Dang C, Le A, Gao P. Myc-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009;15:6479-6483.
15. Gao P, Tchernyshyov I, Chang T, et al. C-myc suppression of mir-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458:762-765.
16. Dang CV. Pkm2 tyrosine phosphorylation and glutamine metabolism signal a different view of the Warburg effect. Sci Signal. 2009;2:pe75.
17. Dang CV. Myc, micrornas and glutamine addiction in cancers. Cell Cycle. 2009;8:3243-3245.
18. Erickson J, Cerione R. Glutaminase: a hot spot for regulation of cancer cell metabolism? Oncotarget. 2010;1:734-740.
19. Wang JB, Erickson JW, Fuji R, et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell. 2010;18:207-219.
20. Conlon KC, Bading JR, DiResta GR, Corbally MT, Gelbard AS, Brennan MF. Validation of transport measurements in skeletal muscle with N-13 amino acids using a rabbit isolated hindlimb model. Life Sci. 1989;44:847-859. (Pubitemid 19085263)
21. Qu W, Zha Z, Ploessl K, et al. Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. J Am Chem Soc. 2011;133:1122-1133.
22. Surti S, Karp JS, Perkins AE, et al. Imaging performance of A-PET: a small animal PET camera. IEEE Trans Med Imaging. 2005;24:844-852. (Pubitemid 41118461)
23. 11C]amino acid synthesis. Int J Rad Appl Instrum [A]. 1987;38:97-102.
24. Moorthy JN, Singhal N. Facile and highly selective conversion of nitriles to amides via indirect acid-catalyzed hydration using TFA or AcOH-H2SO4. J Org Chem. 2005;70:1926-1929. (Pubitemid 40300163)
25. 11C]glutamate. J Labelled Comp Radiopharm. 2001;44:287-294.
26. Dang CV. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle. 2010;9:3884-3886.
27. McGivan JD, Bungard CI. The transport of glutamine into mammalian cells. Front Biosci. 2007;12:874-882. (Pubitemid 46846863)
28. Plathow C, Weber WA. Tumor cell metabolism imaging. J Nucl Med. 2008;49 (suppl 2):43S-63S. (Pubitemid 351948036)
29. McConathy J, Goodman Mark M. Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography. Cancer Metastasis Rev. 2008;27:555-573.
30. 18F]FACBC) in rat 9L gliosarcoma. Bioorg Med Chem Lett. 2010;20:2140-2143.
31. 18F] fluorocyclobutyl-1- carboxylic acid as a potential positron emission tomography brain tumor imaging agent. Bioorg Med Chem. 2009;17:1982-1990.
32. Nye JA, Jarkas N, Schuster DM, et al. Biodistribution and human dosimetry of enantiomer-1 of the synthetic leucine analog anti-1-amino-2- fluorocyclopentyl- 1-carboxylic acid. Nucl Med Biol. 2011;38:1035-1041.
33. 111In-capromab pendetide SPECT/CT. Radiology. 2011;259:852-861.
34. Okudaira H, Shikano N, Nishii R, et al. Putative transport mechanism and intracellular fate of trans-1-amino-3-118F-fluorocyclobutanecarboxylic acid in human prostate cancer. J Nucl Med. 2011;52:822-829.
35. 18F] fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2006;33:287-294.
36. 18F- (2S,4R) 4-fluoroglutamine. J Nucl Med. 2011;52:1947-1955.
37. 2]-l-glutamine for hyperpolarized MRS imaging of cancer cell metabolism. Acad Radiol. 2011;18:932-939.